Journal article · 2025 · Open access

Advances in Artificial Intelligence for Drug Discovery and Development: A Review of Current Trends and Applications

E.Bharath, T.S.Thilagavathi, D.Jeeva, S. Anbazhagan, S.A.Vadivel

Asian Journal of Pharmaceutical Research and Development, 13(2), 67–78 · Published 15 April 2025 · DOI 10.22270/ajprd.v13i2.1541

Free PDFView at the publisherCite this paper

In brief

“Advances in Artificial Intelligence for Drug Discovery and Development: A Review of Current Trends and Applications” is a 2025 journal article by E.Bharath and 4 co-authors, published in Asian Journal of Pharmaceutical Research and Development. OpenAlex counts 3 citations as of 15 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at Asian Journal of Pharmaceutical Research and Development.

Citations
3
Most cited in
2026 (2)
Field-weighted impact
0.86
References
30
Authors
5

Abstract

The rapid advancement of Artificial Intelligence (AI) has revolutionized drug discovery and development, reshaping the pharmaceutical landscape with its computational power and data-driven approaches. AI-driven methodologies, including deep learning, machine learning, and neural networks, have significantly expedited target identification, lead optimization, and drug repurposing, thereby reducing both time and cost associated with traditional drug development. Virtual screening, molecular docking, and predictive modelling have enabled more precise drug-target interactions, enhancing therapeutic efficacy and minimizing potential adverse effects. Moreover, AI's integration into chemical synthesis, polypharmacology, and biomarker discovery has expanded its applications in personalized medicine. This review explores the latest trends and applications of AI in drug discovery, emphasizing its role in optimizing drug design, predicting novel therapeutics, and improving preclinical and clinical trial success rates. While AI has demonstrated remarkable potential, challenges such as data bias, interpretability, and regulatory concerns remain critical barriers to its full-scale implementation. Addressing these challenges will be essential to unlocking AI’s transformative capabilities in revolutionizing modern drug development.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

E.Bharath, T.S.Thilagavathi, D.Jeeva, Anbazhagan, S., & S.A.Vadivel. (2025). Advances in Artificial Intelligence for Drug Discovery and Development: A Review of Current Trends and Applications. Asian Journal of Pharmaceutical Research and Development, 13(2), 67–78. https://doi.org/10.22270/ajprd.v13i2.1541

MLA 9

E.Bharath, et al. “Advances in Artificial Intelligence for Drug Discovery and Development: A Review of Current Trends and Applications.” Asian Journal of Pharmaceutical Research and Development, vol. 13, no. 2, 2025, pp. 67–78. https://doi.org/10.22270/ajprd.v13i2.1541.

Chicago

E.Bharath, T.S.Thilagavathi, D.Jeeva, S. Anbazhagan, and S.A.Vadivel. 2025. “Advances in Artificial Intelligence for Drug Discovery and Development: A Review of Current Trends and Applications.” Asian Journal of Pharmaceutical Research and Development 13 (2): 67–78. https://doi.org/10.22270/ajprd.v13i2.1541.

Harvard

E.Bharath et al. (2025) ‘Advances in Artificial Intelligence for Drug Discovery and Development: A Review of Current Trends and Applications’, Asian Journal of Pharmaceutical Research and Development, 13(2), pp. 67–78. doi:10.22270/ajprd.v13i2.1541.

IEEE

E.Bharath, T.S.Thilagavathi, D.Jeeva, S. Anbazhagan, and S.A.Vadivel, “Advances in Artificial Intelligence for Drug Discovery and Development: A Review of Current Trends and Applications,” Asian Journal of Pharmaceutical Research and Development, vol. 13, no. 2, pp. 67–78, 2025, doi: 10.22270/ajprd.v13i2.1541.

BibTeX

@article{ebharath2025advances,
  title     = {{Advances in Artificial Intelligence for Drug Discovery and Development: A Review of Current Trends and Applications}},
  author    = {E.Bharath and T.S.Thilagavathi and D.Jeeva and Anbazhagan, S. and S.A.Vadivel},
  journal   = {Asian Journal of Pharmaceutical Research and Development},
  year      = {2025},
  volume    = {13},
  number    = {2},
  pages     = {67--78},
  doi       = {10.22270/ajprd.v13i2.1541},
  url       = {https://doi.org/10.22270/ajprd.v13i2.1541}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • artificial intelligence in drug discovery
  • drug development
  • deep learning
  • machine learning
  • virtual screening
  • molecular docking
  • drug repurposing
  • target identification

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

E.Bharath, T.S.Thilagavathi, D.Jeeva, Anbazhagan, S., & S.A.Vadivel. (2025). Advances in Artificial Intelligence for Drug Discovery and Development: A Review of Current Trends and Applications. Asian Journal of Pharmaceutical Research and Development, 13(2), 67–78. https://doi.org/10.22270/ajprd.v13i2.1541

How many times has this paper been cited?

3 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Asian Journal of Pharmaceutical Research and Development.

Who wrote this paper?

E.Bharath, T.S.Thilagavathi, D.Jeeva, S. Anbazhagan, S.A.Vadivel.

What is the DOI of this paper?

10.22270/ajprd.v13i2.1541. The permanent link is https://doi.org/10.22270/ajprd.v13i2.1541.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.